Kyongbo Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,228	4,128	4,477	6,348	4,290
Short-Term Investments	820	2,000	870	870	-
Cash & Short-Term Investments	8,048	6,128	5,347	7,218	4,290
Cash Growth	31.34%	14.60%	-25.92%	68.25%	-79.55%
Accounts Receivable	63,268	51,624	56,160	50,202	46,906
Other Receivables	1,392	686.7	697.94	597.63	988.69
Receivables	64,660	52,311	56,858	50,799	47,895
Inventory	80,977	90,585	70,664	57,443	57,670
Prepaid Expenses	694.32	1,311	1,610	115.43	913.7
Other Current Assets	4,758	1,606	1,423	749.74	397.53
Total Current Assets	159,138	151,941	135,902	116,326	111,166
Property, Plant & Equipment	128,023	99,852	96,073	93,919	95,677
Long-Term Investments	10,202	11,121	13,676	11,935	14,384
Other Intangible Assets	3,880	4,008	3,641	3,221	3,355
Long-Term Deferred Tax Assets	13,587	13,565	13,203	11,951	10,179
Other Long-Term Assets	4,708	3,399	3,810	3,194	2,218
Total Assets	319,538	283,887	266,305	240,545	236,979
Accounts Payable	14,771	14,951	22,775	14,742	16,404
Accrued Expenses	4,102	3,537	3,398	2,793	2,553
Short-Term Debt	101,321	89,271	73,095	63,900	55,234
Current Portion of Long-Term Debt	-	45	90	90	90
Current Portion of Leases	1,010	1,074	1,078	280.59	787.02
Current Income Taxes Payable	-	86.85	118.34	166.28	-
Other Current Liabilities	26,045	23,695	17,707	13,596	13,746
Total Current Liabilities	147,249	132,660	118,261	95,569	88,814
Long-Term Debt	24,000	-	45	135	225
Long-Term Leases	340.27	1,043	1,629	106.58	250.75
Pension & Post-Retirement Benefits	114.83	1,482	-	-	927.43
Other Long-Term Liabilities	2,096	2,548	1,988	1,030	1,061
Total Liabilities	173,800	137,733	121,924	96,841	91,278
Common Stock	11,953	11,953	11,953	11,953	11,953
Additional Paid-In Capital	40,067	40,067	40,067	40,067	40,067
Retained Earnings	98,125	98,333	96,033	94,695	94,587
Comprehensive Income & Other	-4,408	-4,199	-3,672	-3,012	-907.41
Shareholders' Equity	145,738	146,154	144,381	143,704	145,701
Total Liabilities & Equity	319,538	283,887	266,305	240,545	236,979
Total Debt	126,671	91,433	75,936	64,512	56,587
Net Cash (Debt)	-118,623	-85,305	-70,589	-57,294	-52,296
Net Cash Per Share	-5205.77	-3567.15	-2952.68	-2439.66	-2190.88
Filing Date Shares Outstanding	19.43	23.91	23.91	23.91	23.91
Total Common Shares Outstanding	19.43	23.91	23.91	23.91	23.91
Working Capital	11,889	19,281	17,641	20,757	22,352
Book Value Per Share	7501.92	6113.48	6039.33	6011.00	6094.52
Tangible Book Value	141,858	142,146	140,741	140,483	142,346
Tangible Book Value Per Share	7302.19	5945.84	5887.05	5876.26	5954.19
Land	30,146	30,146	28,633	27,569	23,874
Buildings	92,725	82,779	81,336	79,341	76,851
Machinery	136,978	125,238	119,358	113,325	111,022
Construction In Progress	24,850	7,959	1,856	1,444	1,729

Source: S&P Global Market Intelligence. Standard template. Financial Sources.